The Delirium-CS Canada Study

CompletedOBSERVATIONAL
Enrollment

235

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

July 31, 2018

Conditions
Delirium
Trial Locations (12)

T2N 2T9

Foothills Medical Centre, Calgary

T6G 2B7

Mazankowski Alberta Heart Institute, Edmonton

R3C 4J8

St. Boniface General Hospital, Winnipeg

E2L 4L4

New Brunswick Heart Centre, Saint John

B3H 2Y9

QEII Health Sciences Centre, Halifax

L8L2X2

Hamilton General Hospital, Hamilton

N6A 5A5

London Health Sciences Centre, London

L3Y 2P9

Southlake Regional Health Centre, Newmarket

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

M5G 2C4

Toronto General Hospital, Toronto

H1T 1C8

Montreal Heart Institute, Montreal

H3A 1A1

Royal Victoria Hospital, Montreal

All Listed Sponsors
collaborator

Foothills Medical Centre

OTHER

collaborator

Mazankowski Alberta Heart Institute

UNKNOWN

collaborator

London Health Sciences Centre

OTHER

collaborator

Southlake Regional Health Centre

OTHER

collaborator

Toronto General Hospital

OTHER

collaborator

Hamilton Health Sciences Corporation

OTHER

collaborator

Ottawa Heart Institute Research Corporation

OTHER

collaborator

Royal Victoria Hospital, Canada

OTHER

collaborator

Montreal Heart Institute

OTHER

collaborator

New Brunswick Heart Centre

OTHER

collaborator

Queen Elizabeth II Health Sciences Centre

OTHER

lead

St. Boniface Hospital

OTHER

NCT02206880 - The Delirium-CS Canada Study | Biotech Hunter | Biotech Hunter